Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05094037 · ClinicalTrials.gov registry record · NA

Orthotic Treatment of Diabetic Foot Ulcers

A NA study of Diabetic Foot Ulcer, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
175
Enrollment target
2
Study locations

NCT05094037: Recruiting NA study of Diabetic Foot Ulcer, sponsored by VA Office of Research and Development.

NCT05094037 is a NA study of Diabetic Foot Ulcer that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 175 participants, below the 252-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (31% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05094037, a NA study of Diabetic Foot Ulcer, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
175 participants
Enrollment target
2
Study locations

Study Summary

The United States Department of Veterans Affairs spends an estimated $1.5 billion a year on healthcare for patients with diabetes. The prevalence and complications of diabetes increase with age. Therefore, with the aging of the US and Veteran populations, there is an expectation of increased healthcare costs associated with treating diabetes and the associated complications of this disorder. One common complication is the diabetic foot ulcer. Diabetic foot ulcers are expensive to treat, can take a long time to heal and result in a decrease in patient quality of life. Patients remain susceptible to developing more foot ulcers over time. The goal of this project is to reduce the time it takes to heal a diabetic foot ulcer, increase the time between episodes of ulceration and improve the quality of life for diabetic foot ulcer patients.

Primary Outcome

The total time that the orthosis has been worn between clinic visits.

Conditions Studied

Interventions

  • OTHER Counseling
  • DEVICE Removable cam walker boot

Study Locations (2)

Illinois

  • Jesse Brown VA Medical Center, Chicago, IL - Chicago
  • Edward Hines Jr. VA Hospital, Hines, IL - Hines

Trial Details

FieldValue
Enrollment Target 175 participants
Start Date 2023-12-04
Est. Completion 2026-03-31
Phase NA
VA Office of Research and Development

1,668 total trials

What NCT05094037 shows while recruiting

NCT05094037 is an interventional study that assigns participants to a tested intervention. The registered 175 participants enrollment target is mid-sized for trials with a published cap, below the 252-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (31% lower).

The record links to 1 condition, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 2 interventions - of which Counseling is the first listed.

NCT05094037 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT05094037 about?

NCT05094037 is a clinical study titled "Orthotic Treatment of Diabetic Foot Ulcers". The United States Department of Veterans Affairs spends an estimated $1.5 billion a year on healthcare for patients with diabetes. The prevalence and complications of diabetes increase with age. Therefore, with the aging of the US and Veteran populations, there is an expectation of increased healthc...

What is the current status of trial NCT05094037?

This trial is currently recruiting. It is a NA study. The enrollment target is 175 participants. The study started on 2023-12-04. Estimated completion is 2026-03-31.

What conditions does trial NCT05094037 study?

This clinical trial studies the following conditions: Diabetic Foot Ulcer.

What interventions are being tested in trial NCT05094037?

The interventions under investigation include: Counseling (OTHER), Removable cam walker boot (DEVICE).

Who is sponsoring clinical trial NCT05094037?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05094037 being conducted?

This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetic Foot Ulcer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05094037's enrollment target sits among peer trials

175 21st of 67 higher than 47 of 67 other Diabetic Foot Ulcer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetic Foot Ulcer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04722341 · 175 participants · NA

    Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators

  • NCT05165745 · 175 participants · NA

    Stick2PrEP Cisgender Women and Trans Individuals

  • NCT05312255 · 175 participants · NA

    Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

  • NCT05335876 · 175 participants · Phase 3

    Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05094037, the US trial registry maintained by the National Library of Medicine. NCT05094037 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.